BR9803367A - Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos - Google Patents

Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos

Info

Publication number
BR9803367A
BR9803367A BR9803367-0A BR9803367A BR9803367A BR 9803367 A BR9803367 A BR 9803367A BR 9803367 A BR9803367 A BR 9803367A BR 9803367 A BR9803367 A BR 9803367A
Authority
BR
Brazil
Prior art keywords
chromans
medicine
replaced
processes
preparation
Prior art date
Application number
BR9803367-0A
Other languages
English (en)
Inventor
Joachim Dr Brendel
Uwe Dr Gerlach
Hans Jochen Dr Lang
Klaus Dr Weidmann
Original Assignee
Hoescht Marion Roussel Deutsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoescht Marion Roussel Deutsch filed Critical Hoescht Marion Roussel Deutsch
Publication of BR9803367A publication Critical patent/BR9803367A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Patente de Invenção:<B>"CROMANOS SUBSTITUìDOS POR SULFONAMIDA, PROCESSOS PARA A SUA PREPARAçãO, SEU EMPREGO COMO MEDICAMENTO E PREPARADOS FARMACêUTICOS CONTENDO OS MESMOS"<D>. Compostos de fórmula I com os significados dos substituintes indicados nas reivindicações, são substâncias extraordinariamente eficazes para produzir medicamentos para a profilaxia e para a terapia de distúrbios cardiovasculares, especialmente arritmias, para o tratamento da úlcera da região gastrintestinal ou para o tratamento de distúrbios da diarréia.
BR9803367-0A 1997-09-26 1998-09-25 Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos BR9803367A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742508A DE19742508A1 (de) 1997-09-26 1997-09-26 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
BR9803367A true BR9803367A (pt) 2000-05-09

Family

ID=7843708

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9803367-0A BR9803367A (pt) 1997-09-26 1998-09-25 Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos

Country Status (25)

Country Link
US (1) US6177449B1 (pt)
EP (1) EP0906911B1 (pt)
JP (1) JP4422222B2 (pt)
KR (1) KR19990030120A (pt)
CN (1) CN1216763A (pt)
AR (1) AR014915A1 (pt)
AT (1) ATE265445T1 (pt)
AU (1) AU755735B2 (pt)
BR (1) BR9803367A (pt)
CA (1) CA2248300C (pt)
CZ (1) CZ307198A3 (pt)
DE (2) DE19742508A1 (pt)
ES (1) ES2221107T3 (pt)
HR (1) HRP980528A2 (pt)
HU (1) HUP9802155A3 (pt)
ID (1) ID20967A (pt)
IL (1) IL126280A (pt)
NO (1) NO984476L (pt)
NZ (1) NZ332030A (pt)
PL (1) PL328854A1 (pt)
RU (1) RU2220965C2 (pt)
SK (1) SK131898A3 (pt)
TR (1) TR199801903A2 (pt)
TW (1) TW565559B (pt)
ZA (1) ZA988788B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE19858253A1 (de) 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
TW589305B (en) * 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
US7001660B2 (en) 2001-07-16 2006-02-21 Gilbert Garitano Images in solids surfaces
FI20030030A0 (fi) * 2003-01-09 2003-01-09 Orion Corp Uusia yhdisteitä
US7368582B2 (en) 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AU2006234295B2 (en) * 2005-04-12 2011-10-13 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl derivatives and their use as potassium channel blockers
US7714150B2 (en) 2005-04-12 2010-05-11 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
WO2010018867A1 (ja) * 2008-08-14 2010-02-18 日産化学工業株式会社 ジ置換ベンゾピラン化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
FR2639349B1 (fr) 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5428031A (en) 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
EP0807629B1 (de) * 1996-05-15 2004-03-03 Aventis Pharma Deutschland GmbH Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
HRP980528A2 (en) 1999-06-30
HUP9802155A2 (hu) 1999-09-28
ZA988788B (en) 1999-03-26
HUP9802155A3 (en) 2002-04-29
JPH11158171A (ja) 1999-06-15
CZ307198A3 (cs) 1999-04-14
CA2248300C (en) 2008-12-02
DE19742508A1 (de) 1999-04-01
CA2248300A1 (en) 1999-03-26
NO984476D0 (no) 1998-09-25
NZ332030A (en) 2000-04-28
PL328854A1 (en) 1999-03-29
AU755735B2 (en) 2002-12-19
JP4422222B2 (ja) 2010-02-24
RU2220965C2 (ru) 2004-01-10
HU9802155D0 (en) 1998-11-30
IL126280A0 (en) 1999-05-09
TR199801903A3 (tr) 1999-04-21
ATE265445T1 (de) 2004-05-15
ID20967A (id) 1999-04-01
TR199801903A2 (xx) 1999-04-21
TW565559B (en) 2003-12-11
US6177449B1 (en) 2001-01-23
DE59811267D1 (de) 2004-06-03
SK131898A3 (en) 1999-06-11
ES2221107T3 (es) 2004-12-16
EP0906911B1 (de) 2004-04-28
IL126280A (en) 2003-10-31
AR014915A1 (es) 2001-04-11
KR19990030120A (ko) 1999-04-26
AU8708298A (en) 1999-04-15
CN1216763A (zh) 1999-05-19
EP0906911A1 (de) 1999-04-07
NO984476L (no) 1999-03-29

Similar Documents

Publication Publication Date Title
BR0017050A (pt) Oxazolidinonas suebstituìdas e seu emprego na área da coagulação do sangue
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
DE69530389D1 (de) Dexanabinol-derivate und ihre verwendung als neuroprotektive pharmazeutische zusammensetzungen
BR9807824A (pt) Derivados de n-hidróxi-beta-sulfonil-propionamida e seu uso como inibidores de metaloproteinases de matriz
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
BR0016821A (pt) Sulfonamidas e derivados da mesma que modulam a atividade de endotelina
ATE79619T1 (de) Arzneimittel.
NO315647B1 (no) Sulfonyl divalente aryl eller heteroaryl hydroksamsyreforbindelser, anvendelse av samme for fremstilling av et medikament samt farmasöytisksammensetning innbefattende samme
BR9803367A (pt) Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos
BR9713884A (pt) Benzamida heterociclicamente substituìda, usos da mesma e de cetobenzamidoaldeìdos desta, e, preparação medicamentosa.
BR9913003A (pt) 4-amino-2-aril-pirimidinas substituìdas, sua preparação, seu uso e os preparados farmacêuticos contendo as mesmas
DE69224069T2 (de) Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält
BR9611897A (pt) Benzofurano carboxamidas e sulfonamidas
ATE200661T1 (de) Bisaromatische verbindungen, sie enthaltende pharmazeutische und kosmetische zusammensetzungen und verwendungen
DE68906609D1 (de) Dopamin-vorlaeufer.
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
BR0115883A (pt) Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor
BR9804995A (pt) Compostos de anel de 5 membros fundido substituìdos com sulfonamida, seu uso como medicamento e preparações farmacêuticas compreendendo os mesmos
BR9803974A (pt) Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos
FR2713640B1 (fr) Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
BR9803739A (pt) Compostos substituìdos por sulfonamida, processos para sua preparação, seu uso como medicamento ou diagnóstico, e medicamento que os contém.

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1908 DE 31/07/2007.